International Dialysis Center Llc is a medicare approved dialysis facility center in Washington, District Of Columbia and it has 15 dialysis stations. It is located in District Of Columbia county at 1730 Hamlin St Ne, Washington, DC, 20018. You can reach out to the office of International Dialysis Center Llc at (202) 525-5415. This dialysis clinic is managed and/or owned by Davita. International Dialysis Center Llc has the following ownership type - Profit. It was first certified by medicare in February, 2010. The medicare id for this facility is 092525 and it accepts patients under medicare ESRD program.
| Name | International Dialysis Center Llc |
|---|---|
| Location | 1730 Hamlin St Ne, Washington, District Of Columbia |
| No. of Dialysis Stations | 15 |
| Medicare ID | 092525 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1730 Hamlin St Ne, Washington, District Of Columbia, 20018 | |
| (202) 525-5415 | |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
| NPI Number | 1528290590 |
| Doing Business As | International Dialysis Center, Llc |
| Address | 1730 Hamlin St Ne Washington, District Of Columbia, 20018 |
| Phone Number | (954) 474-7701 |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
| NPI Number | 1932468923 |
| Organization Name | International Dialysis |
| Doing Business As | Total Renal Care Inc |
| Address | 1730 Hamlin St Ne Washington, District Of Columbia, 20018 |
| Phone Number | (202) 525-5415 |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 74% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 7% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 19% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 71% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 19% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 10% | 14% |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 60% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 16% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 24% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 67% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 19% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 14% | 12% |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 78% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 22% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 69% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 16% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 15% | 12% |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
| Dialysis patients with Hemoglobin data | 40 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 28 |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 74 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 662 |
| Percentage of adult patients getting regular hemodialysis at the center | 92 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
| Adult patients getting regular peritoneal dialysis at the center | 1 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 7 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at International Dialysis Center Llc with elevated calcium levels.
| Patients with hypercalcemia | 77 |
| Hypercalcemia patient months | 688 |
| Patients with Serumphosphor | 78 |
| Patients with Serumphosphor less than 3.5 mg/dL | 17 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 31 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 30 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 15 |
| Patients with Serumphosphor greater than 7 mg/dL | 7 |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 59 |
| Patient months included in arterial venous fistula and catheter summaries | 492 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 70 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 9 |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 62 |
| Hospitalization Rate in facility | 120 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 238 |
| Hospitalization Rate: Lower Confidence Limit | 62.8 |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
The rate of readmission show you whether patients who were being treated regularly at International Dialysis Center Llc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 27.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 40.4 |
| Readmission Rate: Lower Confidence Limit | 17 |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at International Dialysis Center Llc get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .77 (As Expected) |
| SIR: Upper Confidence Limit | 2.11 |
| SIR: Lower Confidence Limit | .2 |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether International Dialysis Center Llc's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 57 |
| Transfusion Rate in facility | 32.1 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 85.5 |
| Transfusion Rate: Lower Confidence Limit | 13.6 |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
The rate of mortality show you whether patients who were being treated regularly at International Dialysis Center Llc lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 360 |
| Mortality Rate in facility | 14.2 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 20 |
| Mortality Rate: Lower Confidence Limit | 9.8 |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago
Georgetown University Hospital Location: Renal Dialysis Unit, Washington, District Of Columbia, 20007 Phone: (202) 444-3664 |
Washington Hospital Center Location: Section Of Nephrology, Washington, District Of Columbia, 20010 Phone: (202) 877-5645 |
BMA - Dupont Circle Location: 11 Dupont Cir Nw, Washington, District Of Columbia, 20036 Phone: (202) 483-0176 |
BMA - Columbia Heights Location: 106 Irving St Nw, Washington, District Of Columbia, 20010 Phone: (202) 829-0060 |
Greater Southeast Community Dialysis Center Location: 1350 Southern Ave Se, Washington, District Of Columbia, 20032 Phone: (202) 561-0828 |
News Archive
Chest pain patients who have abnormal coronary blood vessel function also have less responsive blood vessels in their fingertips, suggesting that a type of fingertip probe could become a useful screening tool, according to a new study in the Dec. 7, 2004 issue of the Journal of the American College of Cardiology.
Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.
In its continuing actions against counterfeiters of Bowflex® products, fitness company Nautilus, Inc. cooperated with and aided U.S. Immigration and Customs Enforcement (ICE) in obtaining the conviction of Chunchai "Katherine" Yu for bribery and trafficking in counterfeit exercise equipment. Yu was convicted by a federal jury in southern California on July 15, 2010 and faces a maximum sentence of 90 years in prison and fines totalling $12.5 million.
On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.
A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
› Verified 7 days ago